Future in psychopathology research

Schizophrenia Bulletin

Volumn 40, Issue SUPPL. 2, 2014, Pages

  Heckers, Stephan ^a  

^a Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN FUNCTION; CLINICAL RESEARCH; HUMAN; LONGITUDINAL STUDY; MENTAL DISEASE; MENTAL HEALTH; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCHOOL; FORECASTING; MEDICAL RESEARCH; PROCEDURES; PSYCHIATRY; PSYCHOLOGICAL THEORY; TIME;

BIOMEDICAL RESEARCH; FORECASTING; HUMANS; PSYCHIATRY; PSYCHOLOGICAL THEORY; PSYCHOPATHOLOGY; TIME FACTORS;

EID: 84895735406     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt159     Document Type: Article

References (52)

1. Carpenter WT Jr, Strauss JS, Bartko JJ. Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry. 1981;138:948-953.
2. Jaspers K. General Psychopathology. Chicago, IL: The University of Chicago Press; 1963.
3. Sims A. Symptoms in the Mind. An Introduction to Descriptive Psychopathology. London, UK: W.B. Saunders; 1999.
4. Berrios G. The History of Mental Symptoms: Descriptive Psychopathology Since the Nineteenth Century. Cambridge, MA: Cambridge University Press; 1996.
5. Andreasen NC. Understanding schizophrenia: a silent spring? Am J Psychiatry. 1998;155:1657-1659.
6. Andreasen NC. DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull. 2007;33:108-112.
7. Freud S. Psychopathology of Everyday Life. New York: The Macmillan Company; 1914.
8. Widiger TA, Sankis LM. Adult psychopathology: issues and controversies. Annu Rev Psychol. 2000;51:377-404.
9. Fish D. Clinical Psychopathology: Signs and Symptoms. Bristol, UK: John Wright & Sons; 1967.
10. Farmer A, McGuffin P, Williams J. Measuring Psychopathology. Oxford, UK: Oxford University Press; 2002.
11. Wernicke C. Grundriss der Psychiatrie. Nijmegen, The Netherlands: Arts & Boeve Verlag; 2000.
12. Andreasen NC. Brave New Brain. Conquering Mental Illness in the Era of the Genome. New York, NY: Oxford University Press; 2001.
13. Strik W, Dierks T. Biologische Psychopathologie. Stuttgart, Germany: Verlag W. Kohlhammer; 2011.
14. Schramme T, Thome J. Philosophy and Psychiatry. Berlin, Germany: Walter de Gruyter; 2004.
15. Fuchs T. Temporality and psychopathology. Phenomenol Cogn Sci. 2013;12:75-104.
16. Bentall RP. Madness Explained. Psychosis and Human Nature. London, UK: Penguin; 2005.
17. Kahlbaum K. The clinico-diagnostic perspective in psychopathology. 1878. Hist Psychiatry. 2007;18:233-245.
18. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Berlin, Germany: Hirschwald; 1874.
19. Hoff P. Kraepelin E. Clinical section - Part I. In: Berrios G, Porter R, eds. A History of Clinical Psychiatry. New York, NY: New York University Press; 1995:261-279.
20. Heckers S. Making progress in schizophrenia research. Schizophr Bull. 2008;34:591-594.
21. Bostroem A. Zustandsbild und Krankheit in der Psychiatrie. Klinische Wochenschrift. 1923;37/38:1728-1731.
22. Peralta V, Cuesta MJ, Giraldo C, Cardenas A, Gonzalez F. Classifying psychotic disorders: issues regarding categorial vs. dimensional approaches and time frame to assess symptoms. Eur Arch Psychiatry Clin Neurosci. 2002;252: 12-18.
23. Bromet EJ, Kotov R, Fochtmann LJ, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry. 2011;168:1186-1194.
24. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. Achte, vollständig umgearbeitete Auflage. 3. Band. Klinische Psychiatrie. 2. Teil. Leipzig, Germany: Verlag von Johann Ambrosius Barth; 1913.
25. Heckers S. How many bipolar mixed states are there? Harv Rev Psychiatry. 2002;10:276-279.
26. Marneros A. The schizoaffective phenomenon: the state of the art. Acta Psychiatr Scand. 2003;108(suppl 418):29-33.
27. Heckers S. Is schizoaffective disorder a useful diagnosis? Curr Psychiatry Rep. 2009;11:332-337.
28. Kahneman D, Slovic P, Tversky A. Judgment Under Uncertainty: Heuristics and Biases. Cambridge, MA: Cambridge University Press; 1982.
29. Ho BC, Flaum M, Hubbard W, Arndt S, Andreasen NC. Validity of symptom assessment in psychotic disorders: information variance across different sources of history. Schizophr Res. 2004;68:299-307.
30. Insel TR. Rethinking schizophrenia. Nature. 2010;468:187-193.
31. Luhrmann TM. Of Two Minds: The Growing Disorder in American Psychiatry. New York, NY: Knopf; 2001.
32. Havens L. Psychiatric Movements. From Sects to Science. New Brunswick, NJ: Transaction Publishers; 2005.
33. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry. 1993;50: 825-831.
34. Buchanan RW, Carpenter WT. Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis. 1994;182:193-204.
35. Ozomaro U, Wahlestedt C, Nemeroff CB. Personalized medicine in psychiatry: problems and promises. BMC Med. 2013;11:132.
36. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128-137.
37. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012;69:16-26.
38. Fusar-Poli P, Borgwardt S, Crescini A, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011;35:1175-1185.
39. McGrath CL, Kelley ME, Holtzheimer PE, et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry. 2013;70:821-829.
40. Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics. 2010;26:1205-1210.
41. van Os J, Delespaul P, Wigman J, Myin-Germeys I, Wichers M. Beyond DSM and ICD: introducing "precision diagnosis" for psychiatry using momentary assessment technology. World Psychiatry. 2013;12:113-117.
42. Konradi C. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev. 2005;50:142-155.
43. Houston I, Peter CJ, Mitchell A, Straubhaar J, Rogaev E, Akbarian S. Epigenetics in the human brain. Neuropsychopharmacology. 2013;38:183-197.
44. Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, and neurological disease. Science. 2013;341:1237758.
45. Smith DB. Muses, Madmen and Prophets: Hearing Voices and the Borders of Sanity. New York, NY: Penguin Books; 2008.
46. Sacks O. Hallucinations. New York, NY: Knopf; 2012.
47. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29:879-889.
48. Oorschot M, Kwapil T, Delespaul P, Myin-Germeys I. Momentary assessment research in psychosis. Psychol Assess. 2009;21:498-505.
49. Allen P, Modinos G, Hubl D, et al. Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr Bull. 2012;38:695-703.
50. Homan P, Kindler J, Hauf M, Hubl D, Dierks T. Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations. Transl Psychiatry. 2012;2:e189.
51. Homan P, Kindler J, Hauf M, Walther S, Hubl D, Dierks T. Repeated measurements of cerebral blood flow in the left superior temporal gyrus reveal tonic hyperactivity in patients with auditory verbal hallucinations: a possible trait marker. Front Hum Neurosci. 2013;7:304.
52. Heckers S, Woodward ND, Ongur D. Neuroimaging of psychotic disorders. In: Charney DS, Buxbaum J, Sklar P, Nestler EJ, eds. Neurobiology of Mental Illness. Oxford, UK: Oxford University Press; 2013.